Our previous studies showed that FTO protects CRC cells from ferroptotic cell death, thus, we wonder whether pharmacological blocking of FTO would as a potential therapeutic approach in cancer with a ferroptotic cell death. This evidence concerns the gene FTO and colorectal carcinoma.